Annual report pursuant to Section 13 and 15(d)

Earnings Per Share

Earnings Per Share

12 Months Ended

Sep. 30, 2024

Note 15: Earnings Per Share

Net income per share is calculated using the weighted average number of shares of common stock outstanding during the applicable period. Basic weighted average common shares outstanding do not include shares of restricted stock that have not yet vested, although such shares are included as outstanding shares in the Company’s Consolidated Balance Sheet. Diluted net income per share is computed using the weighted average number of common shares outstanding and if dilutive, potential common shares outstanding during the period. Potential common shares consist of the additional common shares issuable in respect of restricted share awards, stock options and convertible preferred stock. Preferred stock dividends are subtracted from net earnings to determine the amount available to common stockholders.

The following table presents the computation of basic and diluted net income per share:


	Years Ended September 30,
	2024		2023
Basic
Net loss	$	(26,685)	$	(102)


Weighted average common shares outstanding	3,147,646		3,133,554
Basic loss per share	$	(8.48)	$	(0.03)
Diluted
Net loss applicable to common stock	$	(26,685)	$	(102)


Weighted average common shares outstanding	3,147,646		3,133,554



Assumed weighted average common shares outstanding	3,147,646		3,133,554
Diluted loss per share	$	(8.48)	$	(0.03)

Basic earnings per common share ("EPS") is computed by dividing net income by the weighted average number of shares of Common Stock outstanding for the period. Diluted EPS is computed by dividing net income by the sum of the weighted average number of shares of Common Stock outstanding and the effect of dilutive securities. No diluted EPS computation was made for the years ended September 30, 2024 and 2023, as the Company recorded a net loss. Had the Company calculated diluted EPS for the years ended September 30, 2024 and 2023, the total assumed weighted average common shares outstanding would have been 3,162,456 and 3,153,033, respectively, and there would have been 35,000 and 22,500 options to purchase shares of common stock that were anti-dilutive, and not included in the years ended September 30, 2024 and 2023 diluted earnings per share computations, respectively.